Sylvain R.
- Country
- France
- Department
- Neurologie fonctionnelle et épileptologie
Research Overview
- A Randomized Phase 2 Study of Adjunctive EQU-001 for Uncontrolled Focal Onset Seizures
- [18F]CPFPX PET Assessment of Brainstem Adenosine A1 Receptor Distribution in Drug-Resistant Epilepsy Under Hypercapnic Challenge
- Phase 2a Open‑Label Study of Adjunctive PTI5803 (Probenecid) in Adolescents and Adults (≥14 y) With Drug‑Resistant Seizures Due to Focal Cortical Dysplasia
Data & Insights
Has run more than one trial at 143 of 202 partner sites.
Specializations
Complex Epilepsy Management
The investigator specializes in treating refractory status epilepticus and refractory focal onset epilepsy, exploring innovative therapeutic approaches for patients who don't respond to conventional treatments.
- Status Epilepticus Management
- Drug-Resistant Epilepsy
- Adjunctive Therapy Development
Research extends to evaluating novel therapeutic compounds for treatment-resistant seizure conditions.
Specialized Seizure Disorders
Focuses on treating distinct epilepsy subtypes including primary generalized tonic-clonic seizures and Dravet syndrome. The investigator also studies tuberous sclerosis complex related epilepsy.
- Genetic Epilepsy Syndromes
- Tonic-Clonic Seizure Management
- Pediatric Epilepsy Conditions
Expertise encompasses both adult and pediatric epilepsy manifestations.
Emergency Seizure Intervention
Investigates rapid-acting treatments for stereotypical prolonged seizures and acute seizure episodes, with emphasis on developing interventions for immediate seizure termination.
- Acute Seizure Management
- Emergency Epilepsy Care
- Rapid Intervention Protocols
Specializes in evaluating fast-acting therapeutic options for urgent seizure control.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.